Sunday, June 29, 2008 10:15:52 AM
Bremen Germany -- Bruker Daltonics' new maXis(TM), an Electrospray Ultra-High Resolution tandem Time of Flight (UHR-Qq-TOF) mass spectrometer demonstrates Bruker's leadership in cutting-edge mass spectrometers.
It is designed to meet future requirements in applications including small molecule identification, metabolomics, quantitative proteomics, as well as biomarker discovery and validation.
The maXis is unique in offering simultaneous no-compromise ultra-high resolution of 40,000 - 60,000 FWHM over a broad mass range, MS and MS/MS mass accuracy typically between 600 and 800 ppb, and all at speeds of up to 20 full spectra per second.
With its unprecedented performance combination, the maXis offers:
-- 20 Hz full spectra acquisition at ultra-high mass resolution
for high-speed liquid chromatography
-- 40,000 - 60,000 resolution in both MS and MS/MS mode over a
broad mass range
-- excellent high m/z mass range
-- novel IonCooler(TM) technology delivers excellent MS/MS
sensitivity over a broad m/z range
-- high dynamic range of 5 orders of magnitude for trace
detection in complex mixtures
-- sub-ppm mass accuracy in both MS and MS/MS mode for high
confidence IDs
-- uncompromised MS sensitivity for discovery applications
-- SmartFormula(TM) 3D unambiguous determination of molecular sum
formulae for molecules up to 1 kDalton;
"Now ultra-high resolution mass spectrometry over broad mass ranges is finally compatible with ultra performance liquid chromatography," explained Bruker Daltonics Executive Vice President Dr. Ian Sanders.
"Our new maXis indeed represents a major step forward in tandem mass spectrometry, offering a no-compromise solution for exceptional accurate mass, ultra-high resolution over a broad mass range and high sensitivity MS and MS/MS analysis at a speed able to take full advantage of modern, fast liquid chromatography or fast capillary electrophoresis separations."
Dr. Richard Joyce, Structural Elucidation Scientist at Pfizer (UK), commented: "It is vital to us to solve real-life identification problems in a dramatically reduced time: our joint development of SmartFormula 3D applied at maXis performance levels meets our goal of a one-shot Molecular Formula Machine."
For more information about Bruker Daltonics and Bruker Corporation (NASDAQ: BRKR), please visit www.bdal.com and www.bruker.com.
Bruker Daltonik GmbH
Fahrenheitstr. 4
28359 Bremen, Germany
http://www.measurementdevices.com/index.php?name=News&file=article&sid=1324
Recent BRKR News
- Bruker Corporation to Present at Upcoming Investor Conferences • Business Wire • 08/23/2024 08:01:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/16/2024 08:39:29 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 08/15/2024 09:41:32 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/13/2024 08:40:12 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/13/2024 08:39:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/13/2024 08:38:45 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/13/2024 08:37:47 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/13/2024 08:36:50 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/13/2024 08:35:48 PM
- Bruker Announces Successful Installation of 1.2 GHz Avance® NMR Spectrometer at the Korea Basic Science Institute (KBSI) • Business Wire • 08/13/2024 05:35:00 PM
- Bruker Announces Quarterly Dividend • Business Wire • 08/12/2024 11:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/07/2024 08:07:09 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/07/2024 08:05:11 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/07/2024 08:03:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/07/2024 12:30:50 PM
- Bruker Announces Strategic Minority Investment in NovAliX • Business Wire • 08/07/2024 11:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/06/2024 11:00:08 AM
- Bruker Reports Second Quarter 2024 Financial Results • Business Wire • 08/06/2024 11:00:00 AM
- Bruker Announces Date and Time of Second Quarter 2024 Earnings Release and Webcast • Business Wire • 07/31/2024 08:05:00 PM
- Bruker Announces that Injunction Impacting NanoString’s CosMx Spatial Molecular Imager Products in Germany Has Been Suspended Effective Immediately • Business Wire • 07/18/2024 11:00:00 AM
- Bruker Announces Successful Installation of a 1.2 GHz NMR at the Leibniz Forschungsinstitut für Molekulare Pharmakologie (FMP) in Berlin • Business Wire • 07/02/2024 11:00:00 AM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 06/05/2024 08:30:30 PM
- Bruker Launches Transformative neofleX™ MALDI-TOF System for Spatial Biology Mass Spec Imaging (MSI) Applications • Business Wire • 06/03/2024 11:00:00 AM
- Bruker Launches Ultimate Sensitivity timsTOF Ultra 2 to Enable New Research Paradigms in Single-Cell and Subcellular Proteomics • Business Wire • 06/03/2024 11:00:00 AM
- Bruker Applied Mass Spectrometry Division Showcases High-Performance Solutions for Research and Analysis in Applied Laboratories • Business Wire • 06/03/2024 11:00:00 AM
North Bay Resources Commences Operations at Bishop Gold Mill, Inyo County, California; Engages Sabean Group Management Consulting • NBRI • Sep 25, 2024 9:15 AM
CEO David B. Dorwart Anticipates a Bright Future at Good Gaming Inc. Through His Most Recent Shareholder Update • GMER • Sep 25, 2024 8:30 AM
Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • BLOZF • Sep 24, 2024 8:50 AM
Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • INTV • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM